Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.780
-0.015 (-0.84%)
At close: Aug 13, 2025, 4:00 PM
1.790
+0.010 (0.56%)
After-hours: Aug 13, 2025, 7:47 PM EDT
Humacyte Market Cap
Humacyte has a market cap or net worth of $281.90 million as of August 13, 2025. Its market cap has decreased by -70.19% in one year.
Market Cap
281.90M
Enterprise Value
327.83M
1-Year Change
-70.19%
Ranking
Category
Stock Price
$1.78
Market Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $281.90M, an increase of 126.78%. That is a compound annual growth rate of 19.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 284.28M | -56.25% |
| Dec 31, 2024 | 649.78M | 120.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | 130.74M | 5.17% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 569.79B |
| Johnson & Johnson | 415.53B |
| AbbVie | 349.88B |
| UnitedHealth Group | 236.21B |
| AstraZeneca | 229.47B |
| Novartis AG | 228.69B |
| Abbott Laboratories | 226.57B |
| Novo Nordisk | 222.88B |